TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Herb Pharma Sverige AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
316
|
351 | |
| Financial expenses |
1
|
2 | |
| Earnings before taxes |
-14
|
-13 | |
| EBITDA |
-2
|
5 | |
| Total assets |
224
|
272 | |
| Current assets |
197
|
233 | |
| Current liabilities |
80
|
95 | |
| Equity capital |
136
|
153 | |
| - share capital |
9
|
9 | |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
60.7%
|
56.2% | |
| Turnover per employee |
158
|
176 | |
| Profit as a percentage of turnover |
-4.4%
|
-3.7% | |
| Return on assets (ROA) |
-5.8%
|
-4.0% | |
| Current ratio |
246.2%
|
245.3% | |
| Return on equity (ROE) |
-10.3%
|
-8.5% | |
| Change turnover |
-24
|
54 | |
| Change turnover % |
-35%
|
-7%
|
18% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.